Catalyst Wire Dossier Catalyst Wire Dossier

Loratadine / Pseudoephedrine Sulfate Extended-Release Tablets 10 mg / 240 mg

loratadine and pseudoephedrine sulfate extended-release · Ranbaxy Laboratories Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Loratadine / Pseudoephedrine Sulfate Extended-Release Tablets 10 mg / 240 mg, covering 2009-02-06 to 2009-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions [NA]

See pricing